Top Abstract Purchase Related
Home
>
Node
>
Subnode

Screening of new tumor suppressor genes in sporadic colorectal cancer patients

Wang, X.; Zbou, C.; Qiu, G.; Fan, J.; Tang, H.; Peng, Z.

Hepato-Gastroenterology 55(88): 2039-2044

2008

ISSN/ISBN: 0172-6390
PMID: 19260473
Document Number: 628137
The generation mechanism of colorectal cancer (CRC) has not been revealed completely, and it is believed that some unknown tumor-related genes were involved in CRC. The purpose of this study was to screen for unknown tumor suppressor genes (TSGs) in patients with sporadic CRC. Through loss of heterozygosity (LOH) analysis on chromosome 10 in sporadic CRC, we have found that D10S185 (10q23.31-24.33) exhibited a higher LOH frequency in our previous study. In this study, seven polymorphic microsatellite markers were chosen for refined LOH mapping of 10q23.31-24.33 in 83 Chinese patients with sporadic CRC. Based on refined LOH mapping, 51 genes were selected for the microarray-based high throughput screening which was done to identify new genes that are CRC-related. Microarray results were validated by quantitative real-time polymerase chain reaction (qRT-PCR). We found that the average LOH frequency of 10q23.31-24.33 was 35.53%, and that the LOH frequency of D10S1265 correlated to Dukes stage. Through the microarray-based high throughput screening, we found 4 significant down-regulated genes: PLCE1, CPEB3, NKX2-3 and SEMA4G. And the down-regulation of PLCE1 was most significant. The results of qRT-PCR also showed that the expression of PLCE1 was at low levels in cancer tissues compared with normal tissues. It was in relative agreement with the DNA microarray data. This study demonstrated that PLCE1 might be a new tumor suppressor gene related to sporadic colorectal cancer. Further studies should be done to prove it.

Document emailed within 1 workday
Secure & encrypted payments

Pećina-Slaus, N. 1998: Tumor suppressor genes with special emphasis on the APC tumor suppressor gene Lijecnicki Vjesnik 120(7-8): 219-227
Peng, H.Q.; Bailey, D.; Bronson, D.; Goss, P.E.; Hogg, D. 1995: Loss of heterozygosity of tumor suppressor genes in testis cancer Cancer Research 55(13): 2871-2875
Dietrich, P.Y.; Droz, J.P. 1992: Renal cell cancer: oncogenes and tumor suppressor genes La Revue du Praticien 42(10): 1236-1240
Neng, J.; Lang, J. 1995: Clinical significance of ovarian cancer related oncogenes and tumor suppressor genes Zhonghua Fu Chan Ke Za Zhi 30(12): 756-758
Hussain, S.P.; Harris, C.C. 1998: Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes Cancer Research 58(18): 4023-4037
Kagan, J.; Stein, J.; Babaian, R.J.; Joe, Y.S.; Pisters, L.L.; Glassman, A.B.; von Eschenbach, A.C.; Troncoso, P. 1995: Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes Oncogene 11(10): 2121-2126
Hasegawa, A.; Fukushima, T.; Mashiko, M.; Nakano, K.; Suzuki, S.; Endo, Y.; Ohki, S.; Hatakeyama, Y.; Koyama, Y.; Inoue, N.; Takebayashi, Y.; Sekikawa, K.; Takenoshita, S-ichi. 2004: Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas Anticancer Research 24(3b): 2047-2052
Zhuang, Z.; Vortmeyer, A.O.; Pack, S.; Huang, S.; Pham, T.A.; Wang, C.; Park, W.S.; Agarwal, S.K.; Debelenko, L.V.; Kester, M.; Guru, S.C.; Manickam, P.; Olufemi, S.E.; Yu, F.; Heppner, C.; Crabtree, J.S.; Skarulis, M.C.; Venzon, D.J.; Emmert-Buck, M.R.; Spiegel, A.M.; Chandrasekharappa, S.C.; Collins, F.S.; Burns, A.L.; Marx, S.J.; Lubensky, I.A. 1997: Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas Cancer Research 57(21): 4682-4686
Kanno, H.; Kondo, K.; Ito, S.; Yamamoto, I.; Fujii, S.; Torigoe, S.; Sakai, N.; Hosaka, M.; Shuin, T.; Yao, M. 1994: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas Cancer Research 54(18): 4845-4847
Quentin, T.; Henke, C.; Korabiowska, M.; Schlott, T.; Zimmerman, B.; Kunze, E. 2004: Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression Anticancer Research 24(2b): 1011-1023
Chiang, J.-M.; Yeh, C.-Y.; Changehien, C.R.; Chen, J.-S.; Tang, R.; Tsai, W.-S.; Fan, C.-W. 2004: Clinical features of second other-site primary cancers among sporadic colorectal cancer patients--a hospital-based study of 3,722 cases Hepato-Gastroenterology 51(59): 1341-1344
Abdullah, M.; Rani, A.A.; Simadibrata, M.; Fauzi, A.; Syam, A.F. 2012: The value of fecal tumor M2 pyruvate kinase as a diagnostic tool for colorectal cancer screening Acta Medica Indonesiana 44(2): 94-99
Akiyama, T. 1995: Structure and function of tumor suppressor genes Nihon Rinsho. Japanese Journal of Clinical Medicine 53(11): 2654-2659
Kobayashi, H. 1996: The cell cycle and the tumor suppressor genes Rinsho Byori. Japanese Journal of Clinical Pathology 44(1): 3-11
Gong, K.; Zhang, Z.; Xin, D. 2001: Frequent somatic mutations of the von Hippel-Lindau tumor suppressor gene in primary sporadic human renal clear cell carcinomas Zhonghua Yi Xue Za Zhi 81(3): 142-144
Miyaki, M.; Okamoto, M.; Seki, M.; Tanaka, K. 1990: Detection of tumor suppressor genes by use of RFLP markers Nihon Rinsho. Japanese Journal of Clinical Medicine 48(8): 236-242
Fujimoto, Y. 1994: Aberrations of tumor suppressor genes in hepatocellular carcinomas Hokkaido Journal of Medical Science 69(5): 1252-1260
Huang, Q.; Tao, Y.; Yandell, D.W. 1999: Mutations of several tumor suppressor genes in primary retinoblastoma Zhonghua Zhong Liu Za Zhi 21(1): 10-12
Clarke, A.R. 1996: The role of the tumor suppressor genes p53 and Rb-1 in development and cell death Birth Defects Original Article Series 30(1): 261-268
Horikawa, I.; Oshimura, M. 1995: Studies on tumor suppressor genes by gene/chromosome transfer Nihon Rinsho. Japanese Journal of Clinical Medicine 53(11): 2647-2652